The World Health Organization (WHO) has approved a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use.
The decision will allow CoronaVac to be used in WHO’s vaccine-sharing program, COVAX, which seeks to provide equitable global access to immunizations.
It is the second Chinese vaccine given WHO approval after Sinopharm was approved in early May.
WHO Director-General Tedros Adhanom Ghebreyesus said at a news briefing Tuesday that CoronaVac was “found to be safe, effective, and quality-assured following two doses of the inactivated vaccine.”
WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has recommended the vaccine for people over 18. Two doses should be spaced between two and four weeks.
Unlike some other vaccines, CoronaVac doesn’t need to be kept at super-cold temperatures.
more recommended stories
Navigating Through Turbulence: The Role of Somalia’s Foreign Ministry in Shaping Future Relations with Somaliland.By: Abdi Jama In the nuanced.
A Vision for Change: Dr. Abdirahman Irro’s Blueprint for Somaliland’s FutureDr. Abdirahman Mohamed Abdillahi Irro, a.
Past, Present, and Future of Somaliland: A Nation at the CrossroadsThe story of Somaliland is marked.
The High Cost of Non-Visionary Leadership: Analyzing Somaliland under President Colonel Muse BihiBy: Abdi Jama In the intricate.